Nephrogen raised an undisclosed amount to engineer AI-driven gene delivery vectors for kidney and pancreatic diseases, enabling researchers and clinicians to advance genomic therapies and improve patient outcomes.
Nephrogen raised an undisclosed amount to engineer AI-driven gene delivery vectors for kidney and pancreatic diseases, enabling researchers and clinicians to advance genomic therapies and improve patient outcomes.
